Upcoming event

Tags

5α-Reductase inhibitors, Aanticoagulants, Actigraphy, Adenotonsillectomy, Adolescent, Antegrade ejaculation, Antidiuretic, Antimuscarinics, Apnea, Aquablation, Arousal, AUA21, Avanafil, Benign Prostatic Diseases, BHP, bipolar TURO, Bladder, Bladder capacity, Bladder injury, Bladder outlet obstruction, Bladder trauma, BNC, BOO, BOOI, BPD, BPE, BPH, BPO, Chronic bacterial prostatitis, Circadian rhythms, Clinical practice guidelines, Clinical trial, Corticotropin-releasing factor, CP/CPPS, CPPS, Curriculum, Depression, Desmopressin, Detrusor, Detrusor hypocontractility, Detrusor overactivity, Diagnosis, Dihydrotestosterone, Drug adherence, Drug therapy, Dutasteride, EAU, EAU21, Ejaculation, Ejaculation preservation, Ejaculatory dysfunction, Endoscopic surgery, Enuresis, Epidemiology, Erectile dysfunction, Fexapotide triflutate, Fibrosis, Finasteride, Fractures, Frequency volume chart, GL-XPS, GreenLight laser, Guidelines, Herbal medicines, HoLEP, Hypogonadism, Hypoxia, IC/BPS, ICS21, Impaired contractility, Incontinence, Infection, Infertility, Inflammation, Inflammatory biomarkers, Innervation, IPP, IPSS, iTIND, Laparoscopy, Laser Bipolar, Laser prostatectomy, Laser therapy, LUT, LUTS, Major cardiac adverse event, Male LUTS, Management of Non-Neurogenic LUTS incl. BPO, Masterclass on BPO, Masterclass on Lasers in urology, Medical therapy, Melatonin, Meta analysis, Meta regression, Metabolic syndrome, Microbiome, Micturition chart, Minimally invasive surgical therapy, minimally invasive techniques, Mirabegron, Monotherapies, Multiple sclerosis, Muscarinic antagonist, Neuro-urology, Neuromodulation, Neurourology, nitinol, Nocturia, Nocturia Symposium, Nocturia Think Tank, Nocturnal enuresis, Nocturnal Enuresis and Alarm Treatment, Nocturnal Enuresis and Desmopressin, Nocturnal Enuresis and Quality of Life, Nocturnal polyuria, Nocturnal voiding frequency, Noninvasive, NX-1207, OAB, Obesity, Obstructive sleep apnea, Obstructive sleep apnea syndrome, Online curriculum, Overactive bladder, Paediatric Urology, Parental punishment, Pathogenesis, Pathophysiology, Patient satisfaction, Patient-reported outcome, Permixon, Pharmacology, Phenotypically directed multimodal management, Phosphodiesterase type 5 inhibitor, Phosphodiesterase type 5 inhibitors, Phytotherapy, Placebo effect, Plasmakinetic enucleation, Potential risk factors, Prospective study, Prostate, Prostate arterial embolisation, Prostate surgery, Prostate-specific antigen, Prostatectomy, Prostatic, Prostatic arterial embolization, Prostatic artery embolization, Prostatic hyperplasia, Prostatitis, PUL, QoL, Quality of life, Randomized trial, RASP, Remission, Renal function profile, Retrograde ejaculation, Robotic, Robotic surgery, Robotics, Salivary alpha-amylase, Serenoa repens, Sexual Dysfunction, Sexual dysfunctions, Sildenafil, Simple prostatectomy, Sleep quality, Sleep-disordered breathing, Sodium diuresis, Solifenacin, Stem cells, Surgery, Surgical intervention, surgical videos, Sympathetic nervous activity, Systematic review, Tadalafil, Tamsulosin, Telomerase, Testosterone, ThuLEP, TmLRP, Tolterodine, TUR syndrome, TURis, TURP, Ultrasonography, Underactive bladder, urethral implantable device, Urethral injury, Urethral trauma, Urinary incontinence, Urinary Incontinence in Adults, Urinary nerve growth factor, Urinary sphincter, Urinary tract infection, Urodynamic, Urodynamics, Urodynamics techniques, Urolift, Vardenafil, Voiding, Voiding diary, Voiding dysfunction, Water diuresis, Webinar, α-Adrenergic blocker, α-Adrenoceptor antagonists, α-Blocker, α-blockers, α1-Blockers
Show all

Loss of Osteopontin improves urinary function and alters the prostatic immune environment

Medicare national and regional trends in BPH surgery, 2013-2019

Pilot trial for PIVoT: Prevention of recurrent urinary tract infection using vaginal testosterone

Pivotal study of a leadless tibial nerve stimulator for Urgency Urinary Incontinence (UUI): 2-Year outcomes from a single site

Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial

BMJ, March 2022

Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial

J Endocrinol Invest., March 2022

Efficacy and safety of the hexanic extract of serenoa repens vs. watchful waiting in men with moderate to severe LUTS-BPH: Results of a paired matched clinical study

Journal of Clinical Medicine, February 2022

Evaluation and Treatment in Urology for Nocturia Caused by Nonurological Mechanisms: Guidance from the PLANET Study

European Urology Focus, January 2022

Predicting outcomes after intradetrusor onabotulinumtoxina for non-neurogenic urgency incontinence in women

Neurourol Urodyn, January 2022

Preservation of Sexual Function 5 Years After Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia

Sexual medicine, December 2021

Assessment of Frailty and Association With Progression of Benign Prostatic Hyperplasia Symptoms and Serious Adverse Events Among Men Using Drug Therapy

JAMA Netw Open, November 2021

New Ultra-minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia: A Systematic Review and Analysis of Comparative Outcomes

European Urology Open Science, November 2021

Next